A series of patients on anti-TNF therapy referred to a multidisciplinary lung cancer service
- PMID: 22492023
- DOI: 10.1007/s11845-012-0821-x
A series of patients on anti-TNF therapy referred to a multidisciplinary lung cancer service
Abstract
Background: Biological therapies have significantly improved the quality of life of patients with aggressive collagen vascular diseases. Blocking TNF activity may potentially confer a higher malignant potential for patients.
Aims: To identify patients to whom anti-TNF therapies were recently prescribed and were referred to a multidisciplinary lung cancer service.
Methods: Retrospective review of patients over an 18-month period who were referred to a multidisciplinary lung cancer service.
Results: Three patients who underwent recent anti-TNF therapies and presented with solid organ tumours. All had significant additional risks for cancer including smoking and family history and active connective tissue diseases with a past history of immunosuppressive therapies.
Conclusions: Our series highlights the potential malignant risk of anti-TNF theraphy to a general medical audience.
Similar articles
-
Evaluation of the safety of rituximab in combination with a tumor necrosis factor inhibitor and methotrexate in patients with active rheumatoid arthritis: results from a randomized controlled trial.Arthritis Rheum. 2011 Mar;63(3):622-32. doi: 10.1002/art.30194. Arthritis Rheum. 2011. PMID: 21360491 Clinical Trial.
-
Drug-induced lupus in anti-TNF-alpha therapy and its treatment with rituximab.Rheumatol Int. 2012 Oct;32(10):3315-7. doi: 10.1007/s00296-011-2137-y. Epub 2011 Sep 1. Rheumatol Int. 2012. PMID: 21881980
-
Risk of infections in rheumatoid arthritis patients switching from anti-TNF agents to rituximab, abatacept, or another anti-TNF agent, a retrospective administrative claims analysis.Semin Arthritis Rheum. 2013 Aug;43(1):39-47. doi: 10.1016/j.semarthrit.2012.12.024. Epub 2013 Feb 27. Semin Arthritis Rheum. 2013. PMID: 23453683
-
[The pulmonological manifestations of rheumatoid arthritis].Orv Hetil. 2008 Jul 20;149(29):1355-61. doi: 10.1556/OH.2008.28385. Orv Hetil. 2008. PMID: 18617467 Review. Hungarian.
-
Tuberculosis risk in patients treated with non-anti-tumor necrosis factor-α (TNF-α) targeted biologics and recently licensed TNF-α inhibitors: data from clinical trials and national registries.J Rheumatol Suppl. 2014 May;91:56-64. doi: 10.3899/jrheum.140103. J Rheumatol Suppl. 2014. PMID: 24789001 Review.
Cited by
-
APRIL, BCMA and TACI proteins are abnormally expressed in non-small cell lung cancer.Oncol Lett. 2016 Nov;12(5):3351-3355. doi: 10.3892/ol.2016.5095. Epub 2016 Sep 6. Oncol Lett. 2016. PMID: 27900003 Free PMC article.
-
Infliximab Originator, Infliximab Biosimilar, and Adalimumab Are More Effective in Crohn's Disease Than Ulcerative Colitis: A Real-Life Cohort Study.Clin Transl Gastroenterol. 2020 May;11(5):e00177. doi: 10.14309/ctg.0000000000000177. Clin Transl Gastroenterol. 2020. PMID: 32677808 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous